Literature DB >> 23529973

In vivo maps of extracellular pH in murine melanoma by CEST-MRI.

D Delli Castelli1, Giuseppe Ferrauto, Juan Carlos Cutrin, Enzo Terreno, Silvio Aime.   

Abstract

PURPOSE: A novel method based on the use of Yb-HPDO3A as MRI Para-CEST agent for in vivo pH mapping of the tumor region in a melanoma murine model is reported. This method does not require the knowledge of the concentration of the imaging agent.
METHODS: C57BL/6-mice were inoculated with B16-F10 cells. CEST-MR images of tumor and bladder were acquired upon the i.v. administration of Yb-HPDO3A (1.2 mmol/Kg). pH was assessed by the use of a ratiometric method.
RESULTS: Yb-HPDO3A distributes well in the extracellular space of the tumor allowing the detection of good levels of saturation transfer (ST). It is excreted throughout kidneys and accumulated in the bladder thus yielding a strong CEST signal from urine. By comparing the ST% obtained upon selective irradiation of the two OH resonances belonging to the two isomeric forms of Yb-HPDO3A, it has been possible to measure the extracellular pH for each voxel (0.22 mm(3) ). The obtained pH-maps of tumors show a great heterogeneity. Marked differences are associated to tumor staging.
CONCLUSION: The application of Yb-HPDO3A to measure extracellular tumor pH provides a good spatio-temporal resolution and it does not require the prior knowledge of the contrast agent concentration. The herein reported data support the potential clinical translation of Yb-HPDO3A.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CEST agents; MRI; YbHPDO3A; cancer; pH map

Mesh:

Substances:

Year:  2013        PMID: 23529973     DOI: 10.1002/mrm.24664

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  25 in total

1.  Concentration-independent MRI of pH with a dendrimer-based pH-responsive nanoprobe.

Authors:  Mohammed P I Bhuiyan; Madhava P Aryal; Branislava Janic; Kishor Karki; Nadimpalli R S Varma; James R Ewing; Ali S Arbab; Meser M Ali
Journal:  Contrast Media Mol Imaging       Date:  2015-07-14       Impact factor: 3.161

2.  pH imaging of mouse kidneys in vivo using a frequency-dependent paraCEST agent.

Authors:  Yunkou Wu; Shanrong Zhang; Todd C Soesbe; Jing Yu; Elena Vinogradov; Robert E Lenkinski; A Dean Sherry
Journal:  Magn Reson Med       Date:  2015-07-14       Impact factor: 4.668

3.  Formation of platinum (II) as a six member ring for sustained polymeric delivery.

Authors:  Sanjeewa N Senadheera; Ti Zhang; Chad E Groer; M Laird Forrest
Journal:  Eur J Med Chem       Date:  2017-05-06       Impact factor: 6.514

4.  Functional t1ρ imaging in panic disorder.

Authors:  Vincent A Magnotta; Casey P Johnson; Robin Follmer; John A Wemmie
Journal:  Biol Psychiatry       Date:  2013-10-21       Impact factor: 13.382

5.  Advanced cardiac chemical exchange saturation transfer (cardioCEST) MRI for in vivo cell tracking and metabolic imaging.

Authors:  Ashley Pumphrey; Zhengshi Yang; Shaojing Ye; David K Powell; Scott Thalman; David S Watt; Ahmed Abdel-Latif; Jason Unrine; Katherine Thompson; Brandon Fornwalt; Giuseppe Ferrauto; Moriel Vandsburger
Journal:  NMR Biomed       Date:  2016-01       Impact factor: 4.044

6.  Evaluating pH in the Extracellular Tumor Microenvironment Using CEST MRI and Other Imaging Methods.

Authors:  Liu Qi Chen; Mark D Pagel
Journal:  Adv Radiol       Date:  2015

7.  Gear Up for a pH Shift: A Responsive Iron(II) 2-Amino-6-picolyl-Appended Macrocyclic paraCEST Agent That Protonates at a Pendent Group.

Authors:  Pavel B Tsitovich; Jordan M Cox; Joseph A Spernyak; Janet R Morrow
Journal:  Inorg Chem       Date:  2016-11-04       Impact factor: 5.165

8.  A pH-Responsive MRI Agent that Can Be Activated Beyond the Tissue Magnetization Transfer Window.

Authors:  Xiaojing Wang; Yunkou Wu; Todd C Soesbe; Jing Yu; Piyu Zhao; Garry E Kiefer; A Dean Sherry
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-11       Impact factor: 15.336

Review 9.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

10.  Preliminary Results that Assess Metformin Treatment in a Preclinical Model of Pancreatic Cancer Using Simultaneous [18F]FDG PET and acidoCEST MRI.

Authors:  Joshua M Goldenberg; Julio Cárdenas-Rodríguez; Mark D Pagel
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.